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Abstract
Chronic total occlusion (CTO) of coronary arteries are found in about 20% of patients 
undergoing percutaneous coronary intervention (PCI) and in about 50% of post-CABG 
patients. Specialized centers can now achieve success rates of over 85%, which is a result of 
technical advancements in retrograde techniques irrespective of the CTO anatomy. Due to 
the complexity of retrograde CTO-techniques, a consensus paper issued by the EuroCTO-
Club requires interventional cardiologists to have sufficient experience in antegrade 
approaches (>300 antegrade CTO-cases, 50/year) with additional retrograde training (25 
retrograde cases each as first and second operator) before becoming an independent ret-
rograde operator. The increased investment in time and technical resources may only 
be justified if the patient has a clear clinical benefit. However, technical advancements 
and the clearer evidence that complete revascularization can be achieved in patients with 
coronary multivessel disease have attracted growing interest in recent years from inter-
ventional cardiologists in treating CTO. The chapter will review current knowledge in the 
interventional treatment of CTO and focuses on indications and the potential benefits for 
the individual patient being based on the current state of scientific evidence.
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1. Introduction
Chronic total occlusions (CTO) of coronary arteries are defined as a complete coronary arterial 
occlusion (thrombolysis in myocardial infarction, TIMI grade 0) being present for more than 
3 months. About 20% of patients undergoing percutaneous coronary interventions (PCI) 
reveal a CTO, whereas in patients with prior coronary artery bypass grafting (CABG), CTOs 
are even more common in more than 50% [1]. Although registry data demonstrate an improve-
ment of the patients’ symptoms such as angina pectoris or dyspnea [2] and a reduction of 
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adverse cardiac events [3, 4] after successful revascularization of a CTO, the overall clinical 
benefit is still under controversial debate, since prospective randomized controlled studies 
are still lacking [5, 6]. This is due partly to the greater complexity of catheter-based interven-
tional techniques and the higher demand for materials compared to PCIs of nonchronically 
occlusive coronary lesions. In contrast, over the last decade, modern and novel developments 
of special techniques and materials increased the success rates of CTO  revascularization in 
specialized centers toward more than 85% alongside acceptable low complication rates. This 
technical advance and the growing scientific evidence envisaging potential complete coronary 
revascularization in patients suffering from coronary multivessel disease [7, 8] have pushed 
CTO-PCIs into the spotlight of modern interventional cardiology.
2. Indication to revascularize a CTO
In more than 50% left ventricular (LV) function is still preserved in the territory of supply of 
the CTO artery [9], whereas the maintaining supply by collateral connections (CCs) is suf-
ficient for only 20% of CTO patients while preventing exercise-induced myocardial ischemia 
[10, 11]. The fractional flow reserve (FFR) distally of the CTO lesion is usually less than 0.5 
reflecting an insufficient collateral circulation [12]. Accordingly, exercise-testing oftentimes 
reveals an exercise-induced myocardial ischemia in the territory of supply of the chronically 
occluded coronary artery.
No prospective randomized controlled studies have been published yet evaluating clinical 
endpoints in patients with CTO-PCI compared to patients being treated conservatively by 
optimal medical therapy. However, there are numerous observational studies comparing a 
successful with unsuccessful CTO-PCI. A meta-analysis of these retrospective registry data 
show an improvement of angina pectoris and a decrease of consecutive need for CABG sur-
gery after successful CTO-PCI [2].
Although symptoms’ relief instead of prognostic benefit represents the primary indication for 
an elective CTO-PCI, the prognostic aspect is debated increasingly as a potential indication. 
Accordingly, there are still only retrospective cohort studies available suggesting a potential 
prognostic benefit after successful CTO-PCI [13]. The largest CTO registry from the UK data-
base demonstrated a 30% improvement of long-term survival both for patients with success-
ful PCI of at least one CTO as well as for those with complete coronary revascularization in 
13,433 CTO patients [14].
Sub-analyses of the New York State Registry including more than 21,000 patients with elective 
coronary stent implantation showed that a complete revascularization was associated with an 
improved adjusted long-term survival compared to incomplete revascularization including 
CTOs [8]. These data support the concept targeting the complete revascularization including 
the revascularization of coronary CTOs.
Figure 1 shows own data from a recent monocentric analysis including  1,642 CTO-patients. 
The prognostic benefit of a CTO-PCI depends on the extend of coronary artery disease and is 
most prominent in patients with a coronary three-vessel disease [15].
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A main mechanism for a beneficial prognostic influence of a successful CTO-PCI may 
 consist in an improved tolerance for future acute coronary syndromes. A sub-analysis from 
the HORIZONS-AMI-study showed that patients with an ST segment elevation myocardial 
infarction (STEMI) and a concomitant CTO revealed a significantly increased mortality both 
in the acute phase and within long-term follow-up, especially in the presence of a coronary 
three-vessel disease [16]. Another registry database demonstrated that the presence of a CTO 
was associated with the future development of malignant ventricular arrhythmias in patients 
with an ischemia-related LV dysfunction [17].
The so-called EURO-CTO-study has just finished the recruiting phase. It represents the first 
prospective and randomized CTO-study comparing CTO-PCIs with optimal medical treatment 
focusing on the improvement of predefined clinical endpoints (i.e., quality of live at 1 year, death 
or myocardial infarction at 3 years). Furthermore, the prospective DECISION-PCI-study from 
Korea randomizes CTO patients either to PCI or optimal medical treatment in order to evaluate 
the influence of CTO-PCI on cardiovascular mortality and future myocardial infarction at 5 years.
Whether LV function being assessed by cardiovascular magnetic resonance imaging (cMRI) 
might be improved is currently being evaluated within the REVASC-study, in which 200 
patients with CTOs are randomized to PCI or optimal medical treatment. Within a prior 
smaller cMRI study, regional LV function depended on the extend of transmural scarring after 
myocardial infarction [18], whereas a further meta-analysis of registry data demonstrated an 
improvement of global LV ejection  fraction (LVEF) of 4.7% [19].
Figure 1. Adjusted 3-year mortality of 1,642 CTO patients presenting at the University Heart Centre Bad Krozingen, 
Germany. A clear prognostic benefit is shown for complete coronary revascularization, especially in patients with a 
coronary three-vessel disease including a CTO (HR, hazard ratio; CI, confidence interval) a CTO (HR, hazard ratio; CI, 
confidence interval) [15].
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3. Principal approaches during CTO-PCI
As shown in Figure 2, the principal factors on which the indication for revascularization of a 
CTO depends on comprise the following:
• Extend of patient’s symptoms under optimal medical therapy.
• Exercise testing.
• Global and regional ventricular function and viability.
• Severity of coronary artery disease.
• Localization and morphology of the CTO.
Considering these factors before CTO-PCI allows the estimation of the potential benefit for 
the patient, as well as the technical severity and risk being associated with the intervention. 
Using the so-called J-CTO-score reveals optimal graduation of the complexity of the CTO-
lesion itself and is more commonly being applied by experienced CTO operators [20].
The latest European guidelines for myocardial revascularization from the year 2014 [21] rec-
ommended a class IIa, with a level of evidence B (“Percutaneous recanalization of CTOs may 
be considered in patients with suspected ischemia reduction in a corresponding myocardial territory 
and/or angina relief.”), and retrograde recanalization techniques are recommended only by a 
class IIB, level of evidence C (“Retrograde recanalization of CTOs may be considered after a failed 
 antegrade approach or as the primary approach for selected patients.”).
Figure 2. Indications for CTO-revascularization.
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This lower recommendation class compared to the PCI of nonchronically occluded coronary 
lesions is in conflict to the nowadays very high success rates and low complication rates of 
CTO-PCIs being performed by experienced interventionalists. For instance, patients with 
prior CABG and a complex morphology of occluded native coronary arteries as well as 
 consecutively occluded bypasses years after CABG surgery may benefit most from a techni-
cally demanding and long-lasting antegrade-retrograde but finally successful recanalization 
of native coronary arteries, as these patients may become free from limiting symptoms in 
daily life [22].
4. Antegrade recanalization techniques
The close cooperation of members of national and international CTO-expert groups such as 
the EuroCTO-club in collaboration with Japanese CTO-specialists refined and improved spe-
cific CTO techniques for more than 10 years. As a result, their experiences consolidated and 
were summarized including numerous publications about technical approaches and inter-
ventional steps in the so-called expert consensus statements [9, 23, 24].
The primary aim is to advance a coronary guide wire through the CTO lesion into the distal 
true lumen of the coronary artery. Most interventionalists at first apply a soft, polymer-
jacked recanalization wire with a reduced tip diameter, which passes the CTO lesion in 
about 40% into the right direction usually through microchannels or soft tissue at the site 
of the occlusion. In the case of hard and severely calcified parts of the occlusion, a so-called 
“wire escalation strategy” is required using recanalization wires with increasing tip loads. 
Within a next step, a medium-heavy, very well guidable recanalization wire is used, when 
the course of the CTO lesion is unclear. In contrast, when the course of the CTO-lesion is 
recognizable again, a harder recanalization wire with a reduce tip diameter is used, which 
in turn reveals an increasing force to penetrate the CTO-tissue and is targeted actively into 
the true distal coronary arterial lumen. The correct distal position of the wire has to be 
confirmed in two different angulations by contralateral contrast injections through the con-
tralateral coronary artery (i.e., from LCA in the case of RCA-CTO and from RCA in the 
case of LCA-CTO). This makes a double arterial access necessary for most CTO-PCIs. When 
the recanalization wire does not pass the distal end of the CTO into the true vessel lumen, 
the so-called “parallel-wire technique” may be applied. Here, the first wire marks the false 
pathway, whereas a second mostly harder wire is used additionally and usually enters then 
the distal lumen. A crucial technical device are microcatheters—catheters of very narrow 
diameters—which will be advanced over and to the tip of the recanalization wires. They 
secure the achieved recanalization pathway and thereby exchanging to other recanalization 
wires becomes possible.
After successful wire passage through the CTO-lesion, predilation with increasing balloon 
sizes will be performed with final implantation of drug-eluting coronary stents, which ensure 
valuable long-term results [25].
The success rates of the above-described antegrade recanalization techniques reach 55–80% 
depending of characteristics of patients and CTO lesions [26–29].
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5. Retrograde recanalization techniques
In about 50% of CTOs, very complex occlusions are present being characterized by a straight 
nontapered proximal cap, long length or torturous course of the lesion, diffuse alterations 
of the distal vessel, or prior failures of recanalization attempts [20]. Retrograde recanaliza-
tion techniques were introduced by Japanese CTO experts and have increased significantly 
the success rates of these complex CTOs without increasing peri-interventional complication 
rates [30–32]. The main goal of all retrograde techniques is to advance successfully a coronary 
wire to the distal end of the CTO lesion using collateral connections originating from the 
contra-lateral coronary artery. Additionally, ipsilateral retrograde techniques without using 
contra-lateral collaterals can be applied [33, 34]. Figure 3 shows schematically an occlusion of 
the right coronary artery (RCA) and wire positioning using epi-myocardial collateral connec-
tions to the distal end of the CTO (Figure 3A, B). This retrograde wire marks exactly the distal 
end of the occlusion and can afterwards be targeted precisely by an antegrade wire, which 
will be able to be advanced antegradely and parallel to the retrograde “marker” wire into the 
distal vessel lumen (so-called “marker wire” technique, Figure 3C, D).
Figure 3. “Marker-wire” technique (CTO, chronic total occlusion) [34].
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Occasionally, more complex retrograde techniques may be performed, such as the “reverse-
CART” (“controlled antegrade and retrograde tracking”)-technique [35, 36]. Here, balloon 
inflation over the antegrade wire creates space within the CTO lesion, which alleviates the 
entry of the retrograde wire, which may then advance parallel to the antegrade wire into the 
antegrade guiding catheter (Figure 4A, B). A consecutively introduced microcatheter  protects 
Figure 4. “Reverse-CART” (“controlled antegrade and retrograde tracking”) technique [36].
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coronary circulation, and within the microcatheter, a 330-cm long special externalization wire 
can be advanced from retrogradely and outside of the body (so-called “externalization”). 
After wire externalization, balloon dilation and stent implantation will then be performed 
antegradely using the externalization wire.
6. Recanalization strategies
Most CTO lesions can be recanalized by antegrade techniques. In about 30%, a retrograde 
technique is necessary due to the complex morphology of the CTO (Figure 5). An escalation 
of the recanalization strategy is valuable, because an antegrade attempt may be successful in 
the case of a complex morphology of the CTO. Retrograde methods reveal a high technical 
expertise and should only be performed independently by interventional cardiologists with 
sufficient training in antegrade techniques (i.e., >300 antegrade CTO-interventions, >50/year) 
and additional training in retrograde techniques (25 retrograde cases as second and primary 
operator each), as stated in a consensus document of the EuroCTO-club [9]. In the presence 
of high expertise in all recanalization techniques, availability of necessary specific materials 
and a possible widened indication up to 90% of CTOs can be recanalized. However, the high 
• Retrograde passage of 
collaterals 
• Kissing wires (marker wire) 
• Reverse CART 
• Externalizaon 
• Tip-in, rendez-vous 
• Contralateral injecon • „Tapered p“ – wires 
• Microcatheters 
• Parallel wire technique 
Escalating strategy for recanalization 
Antegrade Retrograde 
Figure 5. Escalating strategies for recanalization (CART, controlled antegrade and retrograde tracking).
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technical demand and effort in time with longer radiation exposure are justified only in rec-
ognition of a presumed clinical benefit for the individual patient.
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